West Lafayette, IN, United States of America

Fred E Regnier

This inventor holds 34 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Biological Analysis. Top assignees: Purdue Research Foundation, Perseptive Biosystems Inc., Beyond Genomics, Inc.. Active years: 1990-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred E Regnier. Retrieved from https://idiyas.com/inventor/fred-e-regnier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 4)

% Patents Active = 85.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.7

ph-index = 17

Forward Citations = 867(Granted Patents)

Location History:

Lafayette, IN (US) (1997 - 1998)
West Layayette, IN (US) (2005)
West Lafayette, IN (US) (1990 - 2015)
Carmel, IN (US) (2018 - 2019)

Company Filing History:

18 out of 2,785

Purdue Research Foundation

patents

12 out of 68

Perseptive Biosystems Inc.

patents

1 out of 1

Beyond Genomics, Inc.

patent

4. 1 out of 2

Perfinity Biosciences, Inc.

patents

5. 1 out of 777

Varian Associates, Inc.

patents

6. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2019

Loading Chart...

Areas of Expertise:

Biological Fluid

Analyte Detection

Glycoproteins

Microarrays

Affinity Selection

Electrophoresis

Chromatography

Protein Imaging

Mass Spectrometry

Immunoassay

Separation Columns

Isotope Fractionation

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10281474 - Method for analyzing samples of biological fluid and apparatus for performing the same (2019-05-07),

2. 10018635 - Method for analyzing samples of a biological fluid (2018-07-10),

3. 9134318 - Detection of oxidized polypeptides (2015-09-15),

4. 9068995 - Method for determining derivatized analytes in a separated biological fluid (2015-06-30),

5. 8628977 - Group specific internal standard technology (GSIST) for simultaneous identification and quantification of small molecules (2014-01-14),

6. 8568993 - Detection of glycopeptides and glycoproteins for medical diagnostics (2013-10-29),

7. 8455202 - Affinity selector based recognition and quantification system and method for multiple analytes in a single analysis (2013-06-04),

8. 8298831 - Differentially encoded biological analyzer planar array apparatus and methods (2012-10-30),

9. 7910356 - Multiplexed biological analyzer planar array apparatus and methods (2011-03-22),

10. 7901943 - Materials and methods for controlling isotope effects during fractionation of analytes (2011-03-08),

11. 7867754 - Microarrays for analyte detection (2011-01-11),

12. 7663092 - Method and apparatus for phase contrast quadrature interferometric detection of an immunoassay (2010-02-16),

13. 7449170 - Materials and methods for controlling isotope effects during fractionation of analytes (2008-11-11),

14. 7405831 - Laser scanning interferometric surface metrology (2008-07-29),

15. 6864099 - Affinity selected signature peptides for protein identification and quantification (2005-03-08),

Title: The Innovative Contributions of Fred E. Regnier

Introduction: Fred E. Regnier, located in West Lafayette, IN, has made significant strides in the field of biotechnology with a remarkable portfolio of 34 patents. His innovations primarily focus on the analysis and purification of biological samples, enhancing the accuracy of mass spectrometric analysis.

Latest Patents: Among his latest contributions are two notable patents titled "Method for analyzing samples of biological fluid and apparatus for performing the same." These inventions relate to continuous or near-continuous techniques for the separation and purification of biological samples. By utilizing a transport agent with a core domain and a targeted binding domain, his methods aim to minimize non-targeted analytes, allowing for a more efficient analysis of specific analytes of interest. The transport agents exceed 200 kiloDaltons or 10 nm, combined with size-exclusion based chromatography to effectively separate target-analyte complexes from non-targeted substances.

Career Highlights: Fred has held pivotal roles in esteemed organizations such as the Purdue Research Foundation and Perseptive Biosystems Inc. His expertise has significantly impacted the advancement of biotechnology and analytical chemistry, making him a key figure in these fields.

Collaborations: Throughout his career, Fred has collaborated with esteemed colleagues, including Noubar Boghos Afeyan and Robert C. Dean, Jr. Their partnerships have fostered innovation and driven the development of groundbreaking technologies within the industry.

Conclusion: Fred E. Regnier stands out as a pioneering inventor in the realm of biological analysis. With 34 patents to his name and a commitment to improving methodologies for sample purification and analysis, he continues to influence the future of biotechnology. His collaborative spirit and dedication to innovation make him a valuable asset to the scientific community.

Profile summary based on public USPTO records.